Scott Wolchko | President and Chief Executive Officer |
Alethia Young | Cantor |
Kelsey Goodwin | Guggenheim |
Ted Tenthoff | Piper Jaffray |
Matthew Biegler | Oppenheimer |
Biren Amin | Jefferies |
Mara Goldstein | Mizuho |
Nick Abbott | Wells Fargo |
Daina Graybosch | SVB Leerink |
Welcome to the Fate Therapeutics Second Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Fate's Web site at fatetherapeutics.com.
As a reminder, today's call is being recorded.
I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.